Elon Musk used an October 10 X Takeover appearance to stress how hard Tesla’s Optimus hands remain to engineer and how slowly initial production is likely to ramp. Humanoids Daily and Teslarati reported the remarks on October 12 and 13. The comments add colour on execution risk. They do not, on their own, rewrite previously discussed Fremont-line targets.

For Canadian investors who hold Tesla shares or TSLA-heavy U.S. technology funds, Optimus is still a long-duration story rather than a near-term cash-flow line. The useful distinction is between Musk’s qualitative warning and anything Tesla has quantified in a formal disclosure.

Coverage of the X Takeover comments, as reported by Humanoids Daily and Teslarati, centres on three points:

  • Hands are unusually hard to engineer because of fine motor skill, force control, durable sensors, and replaceable coverings
  • The initial production ramp will be slow
  • China magnet export curbs delayed the program by two to three months last year, prompting more emphasis on U.S. sourcing

A working humanoid hand has to survive repeated use and still perform delicate tasks. That combination of durability, sensing, and dexterity is why a stage demonstration is not the same as a serviceable product. Musk’s “shockingly difficult” phrasing, as relayed by Humanoids Daily, is colour on that gap. It is not a laboratory paper or a Tesla 10-Q.

The slow-ramp warning is likewise qualitative. It fits a program still proving manufacturing. The cited coverage does not provide a new Optimus unit number or a confirmed cut to any public volume guide. Teslarati’s follow-on analysis argued that Musk’s informal target date for buying an Optimus robot is harder than it sounds. That is the outlet’s interpretation of timeline risk, not a Tesla filing.

The magnet point is historical rather than a fresh forecast. Musk said Chinese export restrictions delayed Optimus by two to three months last year. Independent verification of that exact duration is not in the cited articles. The investor-relevant theme is familiar: concentrated supply of specialty magnets and rare-earth inputs can stall even well-funded hardware programs. Musk used the episode to emphasise U.S. sourcing resilience.

Canadian relevance is mostly about China-linked industrial risk and how Optimus sits in a Tesla thesis. Tesla is U.S.-listed, yet it is a common holding in non-registered accounts and registered plans. Humanoid optionality already features in many long-term Tesla narratives. Magnet export controls sit inside a broader critical-minerals story that Canadian investors also encounter through mining, energy, and industrial names. A past two-to-three-month delay is a reminder of that exposure. It does not, by itself, change Tesla’s vehicle business, which still dominates current results.

What is confirmed is the reporting of Musk’s comments by those two outlets. What is not confirmed is a new shipment calendar, a Fremont robot-line capacity figure, or third-party audit of magnet-related downtime. Timing to a generally available robot, factory labour substitution at scale, and any valuation that depends on those outcomes remain speculative.

Equity markets still tend to re-price Tesla first on vehicle deliveries, margins, and energy storage, with humanoids as a longer-dated overlay. Until Tesla reports Optimus units, costs, or customer shipments in a formal channel, these remarks are colour on risk rather than a new operating plan.